Literatur
Cortazar P, Zhang L, Untch M et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet. doi:10.1016/S0140-6736(13)62422-8
Goldhirsch A, Winer EP, Coates AS et al (2013) Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013. Ann Oncol 24:2206–2223
Hellman S, Harris JR (1987) The appropriate breast cancer paradigm. Cancer Res 47:339–342
Kyndi M, Sorensen FB, Knudsen H et al (2008) Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group. J Clin Oncol 26:1419–1426
Kyndi M, Overgaard M, Nielsen HM et al (2009) High local recurrence risk is not associated with large survival reduction after postmastectomy radiotherapy in high-risk breast cancer: a subgroup analysis of DBCG 82 b&c. Radiother Oncol 90:74–79
Punglia RS, Morrow M, Winer EP et al (2007) Local therapy and survival in breast cancer. N Engl J Med 356:2399–2405
Van De Steene J, Soete G, Storme G (2000) Adjuvant radiotherapy for breast cancer significantly improves overall survival: the missing link. Radiother Oncol 55:263–272
Voduc KD, Cheang MC, Tyldesley S et al (2010) Breast cancer subtypes and the risk of local and regional relapse. J Clin Oncol 28:1684–1691
Einhaltung ethischer Richtlinien
Interessenkonflikt
D. Krug gibt an, dass kein Interessenkonflikt besteht.
Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Krug, D. Postoperative Bestrahlung von Thoraxwand und Lymphabflusswegen nach Mastektomie bei Patientinnen mit bis zu 3 befallenen axillären Lymphknoten. Strahlenther Onkol 190, 967–969 (2014). https://doi.org/10.1007/s00066-014-0717-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00066-014-0717-y